These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21098404)

  • 1. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy.
    i Dali C; Hanson LG; Barton NW; Fogh J; Nair N; Lund AM
    Neurology; 2010 Nov; 75(21):1896-903. PubMed ID: 21098404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
    Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
    Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease].
    Engelbrecht V; Rassek M; Gärtner J; Kahn T; Mödder U
    Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
    Aydinli N; Calişkan M; Calay M; Ozmen M
    Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
    Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
    Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
    Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of postmortem interval with multivoxel-voxel proton 1H-MR spectroscopy].
    Yang TT; Li ZW; Liu L; Zheng N
    Fa Yi Xue Za Zhi; 2007 Dec; 23(6):405-8. PubMed ID: 18402106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.
    Gabis L; Wei Huang ; Azizian A; DeVincent C; Tudorica A; Kesner-Baruch Y; Roche P; Pomeroy J
    J Child Neurol; 2008 Jul; 23(7):766-74. PubMed ID: 18487520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALS surrogate markers. MRS.
    Kalra S; Arnold DL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():111-4. PubMed ID: 15512889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
    Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
    Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy.
    Cross JH; Connelly A; Jackson GD; Johnson CL; Neville BG; Gadian DG
    Ann Neurol; 1996 Jan; 39(1):107-13. PubMed ID: 8572655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo.
    Kruse B; Hanefeld F; Christen HJ; Bruhn H; Michaelis T; Hänicke W; Frahm J
    J Neurol; 1993 Dec; 241(2):68-74. PubMed ID: 7908027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.